Filing Flows › Entera Bio (ENTX) › Stock forecast & fair value
Entera Bio (ENTX) stock forecast and price target
Entera Bio (ENTX) trades at $3.14. 4 analysts' median price target is $9.50 (+203%), from $9.00 to $11.00.
Entera Bio's latest quarter
Entera Bio, Q1 2025: revenue $42K, net loss $2.6M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ENTX stock?
The median of 4 analysts' 12-month targets is $9.50, +203% from $3.14; the range is $9.00 to $11.00. The average rating is none.
Does Entera Bio usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is ENTX stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.